Llama antibodies have ‘significant potential’ for treating COVID, UK health officials say
By
Alicia Lasek
Sep 23, 2021
Llama antibodies have shown resounding success in early efficacy trials in animals. If developed into a drug for humans, they could be administered using a nebulizer or nasal spray, investigators say.
Successfully decreasing antipsychotics use
By
Elizabeth Newman
May 01, 2012
If you’re wondering if anyone outside the profession is paying attention to the antipsychotics-use debate in long-term care, allow me to direct your attention to Boston.